Invesco brings portfolio tools to Claude as PR Newswire recaps week's top releases

Invesco and Anthropic target financial advisors

The roundup includes only an excerpt of the Invesco announcement, headlined "Invesco Announces Work with Anthropic to Bring its Custom Portfolio and Practice Management Capabilities to Claude." The excerpt contains no details on pricing, availability or technical scope, so those points remain unknown.

What the excerpt does offer is a quote from John McDonough, Head of Americas Distribution at Invesco. He said: "We believe this will be a major advancement toward helping advisors turn efficient access to Invesco expertise into more meaningful client conversations, stronger practices for their business, and deeper relationships that help the advisor and client grow together." The stated audience is therefore financial advisors, and the goal is faster access to Invesco's expertise.

Other technology and infrastructure stories

Several other items in the roundup touch on AI and computing infrastructure. SWI Compute emerged from stealth with a plan to turn gigawatts of power into NVIDIA AI factories, starting in Europe. CEO Halil Mirakhmedov said: "Energy availability represents the primary bottleneck facing European AI infrastructure." He added that SWI Group spent six years acquiring grid access and is now deploying those power resources through SWI Compute.

Read/Write Labs, formerly Dandelion Science, debuted with what it describes as an industry-first AI platform that writes code for the brain. According to the release excerpt, the new identity reflects a focus on an intelligence layer that can read and write information to the brain through neural interfaces, with the aim of treating a range of disorders and improving cognition.

Formation Bio announced a $600 million debut fund. The company says it combines dedicated capital with its AI-native development platform, and it aims to acquire 10-15 drug programs over the next 3-5 years. Separately, Elementl Power, DS Investment Partners and Samsung C&T proposed a partnership to provide part of the capital for up to three of Elementl's advanced nuclear projects to reach final investment decision.

Health, finance and consumer news

Eli Lilly reported that retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in a head-to-head trial. In adults with type 2 diabetes, according to the release, retatrutide lowered A1C by an average of 2.2% versus 1.8% with Ozempic 2 mg at 80 weeks.

In finance, Disruptive announced a $10 billion flagship fund. It plans to back approximately 10 growth and late-stage companies, investing up to $1 billion per company. S&P Dow Jones Indices and Kalshi announced a collaboration under which Kalshi becomes a preferred prediction market platform licensed for event contracts tied to S&P DJI indices. Villa Vie Residences suspended operations in Cambodia while pursuing restructuring, citing monthly fuel expense per cabin that rose from roughly $1,800 to an estimated $6,000 to $8,000 in parts of Asia.

Consumer items included Mozilla's Come Back to Firefox campaign featuring internet icons such as Numa Numa Guy and Success Kid, Campbell's fifth annual State of the Sides Report, and a limited-time Pop-Tarts and Liquid Death orange toaster pastry due in November 2026. The Conference Board said US consumer confidence increased in October, and Wendy's confirmed receipt of an unsolicited proposal from Trian Partners.

What it means

For readers following AI, the Invesco item shows an asset manager working with Anthropic to make its portfolio and practice management capabilities available inside Claude. Until the full announcement is consulted, the practical details for advisors are not clear from this recap. The roundup also notes that earnings from Instacart, Boeing, Harley-Davidson, Eli Lilly and PayPal were among those released through the wire that week.